Artivion | CRY - Equity Capital And Reserves


Artivion reported $445.58M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 445.58M 4.88M Jun/2026
AtriCure USD 516.43M 24.74M Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Inogen USD 197.18M 2.32M Sep/2025
Integra LifeSciences USD 1.04B 971K Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 429.18M 6.01M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
ResMed USD 6.59B 93.48M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Tandem Diabetes Care USD 130.39M 2.02M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 1.66T 77.51B Jun/2026
Trinity Biotech USD -71.98M 17.26M Dec/2025